• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与糖尿病肾病之间的关联:一项孟德尔随机化研究。

Associations Between Gut Microbiota and Diabetic Nephropathy: A Mendelian Randomization Study.

作者信息

Xiong Yujun, Zhu Xingyun, Xu Huazhao, Zheng Zitian, Luo Qingfeng

机构信息

Department of Gastroenterology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China.

Department of Endocrinology Beijing Jishuitan Hospital Beijing People's Republic of China.

出版信息

Aging Med (Milton). 2025 Feb 18;8(1):e70009. doi: 10.1002/agm2.70009. eCollection 2025 Feb.

DOI:10.1002/agm2.70009
PMID:39968006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11833227/
Abstract

OBJECTIVES

Diabetic nephropathy (DN) is a severe complication of diabetes mellitus, and its pathogenesis remains incompletely understood. Emerging evidence suggests a potential link between gut microbiota and DN. This study aimed to explore the causal relationship between gut microbiota and DN using a two-sample Mendelian randomization (MR) approach.

METHODS

Gut microbiota data were obtained from the MiBioGen consortium, which provides the most comprehensive genome-wide association studies (GWAS) on gut microbiota. Summary-level genetic data for DN were sourced from publicly available GWAS data provided by the FinnGen consortium. The primary analysis was conducted using the inverse variance-weighted (IVW) method, complemented by sensitivity analyses to evaluate pleiotropy and heterogeneity.

RESULTS

Fourteen gut microbiota species demonstrated significant genetic associations with DN in the MR analysis, including five negatively and nine positively associated species, as determined by the IVW method. No evidence of pleiotropy or heterogeneity was observed, ensuring the robustness of the findings.

CONCLUSIONS

This study provides novel insight into the causal role of gut microbiota in DN pathogenesis, uncovering specific microbial species that may contribute to disease progression. These findings offer a promising avenue for future research and therapeutic development targeting gut microbiota.

摘要

目的

糖尿病肾病(DN)是糖尿病的一种严重并发症,其发病机制尚未完全明确。新出现的证据表明肠道微生物群与DN之间可能存在联系。本研究旨在使用两样本孟德尔随机化(MR)方法探讨肠道微生物群与DN之间的因果关系。

方法

肠道微生物群数据来自MiBioGen联盟,该联盟提供了关于肠道微生物群最全面的全基因组关联研究(GWAS)。DN的汇总水平遗传数据来自FinnGen联盟提供的公开可用GWAS数据。主要分析采用逆方差加权(IVW)方法,并辅以敏感性分析以评估多效性和异质性。

结果

在MR分析中,14种肠道微生物物种与DN表现出显著的遗传关联,其中5种呈负相关,9种呈正相关,这是通过IVW方法确定的。未观察到多效性或异质性的证据,确保了研究结果的稳健性。

结论

本研究为肠道微生物群在DN发病机制中的因果作用提供了新的见解,发现了可能导致疾病进展的特定微生物物种。这些发现为未来针对肠道微生物群的研究和治疗开发提供了有希望的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/95555af3fd4b/AGM2-8-e70009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/4c0792416588/AGM2-8-e70009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/beaedc3ad358/AGM2-8-e70009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/b7d17067a77e/AGM2-8-e70009-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/95555af3fd4b/AGM2-8-e70009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/4c0792416588/AGM2-8-e70009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/beaedc3ad358/AGM2-8-e70009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/b7d17067a77e/AGM2-8-e70009-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/11833227/95555af3fd4b/AGM2-8-e70009-g001.jpg

相似文献

1
Associations Between Gut Microbiota and Diabetic Nephropathy: A Mendelian Randomization Study.肠道微生物群与糖尿病肾病之间的关联:一项孟德尔随机化研究。
Aging Med (Milton). 2025 Feb 18;8(1):e70009. doi: 10.1002/agm2.70009. eCollection 2025 Feb.
2
Causal effects of gut microbiota on diabetic neuropathy: a two-sample Mendelian randomization study.肠道微生物群对糖尿病周围神经病变的因果影响:两样本孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Aug 2;15:1388927. doi: 10.3389/fendo.2024.1388927. eCollection 2024.
3
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study.肠道微生物群与糖尿病肾病:一项观察性研究综述及双向孟德尔随机化研究
Trials. 2025 Mar 24;26(1):101. doi: 10.1186/s13063-025-08755-4.
4
Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization.评估肠道微生物群与糖尿病肾病之间的因果关系:来自两样本孟德尔随机化的见解。
Front Endocrinol (Lausanne). 2024 Mar 18;15:1329954. doi: 10.3389/fendo.2024.1329954. eCollection 2024.
5
Causal associations between gut microbiota and premature rupture of membranes: a two-sample Mendelian randomization study.肠道微生物群与胎膜早破的因果关系:两样本孟德尔随机化研究。
Front Immunol. 2024 Sep 2;15:1440232. doi: 10.3389/fimmu.2024.1440232. eCollection 2024.
6
Uncovering a causal connection between the genus in fecal microbiota and non-alcoholic fatty liver disease: a two-sample Mendelian randomization analysis.揭示粪便微生物群中的属与非酒精性脂肪性肝病之间的因果关系:一项两样本孟德尔随机化分析。
Front Microbiol. 2023 Dec 12;14:1276790. doi: 10.3389/fmicb.2023.1276790. eCollection 2023.
7
Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis.阐明欧洲患者肠道微生物群、代谢物与糖尿病肾病之间的因果关系:全基因组双向孟德尔随机化分析的启示
Front Endocrinol (Lausanne). 2025 Jan 8;15:1391891. doi: 10.3389/fendo.2024.1391891. eCollection 2024.
8
Association between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.肠道微生物群与糖尿病肾病的关联:一项两样本 Mendelian 随机研究。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1361440. doi: 10.3389/fendo.2024.1361440. eCollection 2024.
9
Bidirectional two-sample Mendelian randomization analysis unveils causal association between inflammatory cytokines and the risk of diabetic nephropathy.双向两样本 Mendelian 随机化分析揭示了炎症细胞因子与糖尿病肾病风险之间的因果关联。
Sci Rep. 2024 Oct 25;14(1):25425. doi: 10.1038/s41598-024-73800-2.
10
Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis.肠道微生物群与糖尿病肾病的因果关系:孟德尔随机化分析
Front Microbiol. 2024 Jan 3;14:1281361. doi: 10.3389/fmicb.2023.1281361. eCollection 2023.

引用本文的文献

1
Unraveling the role of gut microbiota on the formation of nephrolithiasis: insights from integrated analysis of GWAS, single-cell transcriptomics, bulk RNA sequencing and network Pharmacology.解析肠道微生物群在肾结石形成中的作用:来自全基因组关联研究、单细胞转录组学、批量RNA测序和网络药理学综合分析的见解
Urolithiasis. 2025 Jul 15;53(1):138. doi: 10.1007/s00240-025-01809-x.

本文引用的文献

1
The roles of gut microbiota and its metabolites in diabetic nephropathy.肠道微生物群及其代谢产物在糖尿病肾病中的作用。
Front Microbiol. 2023 Jul 27;14:1207132. doi: 10.3389/fmicb.2023.1207132. eCollection 2023.
2
Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage.经活检证实的糖尿病肾病和长期无肾脏损害的糖尿病患者肠道微生物群的改变。
Sci Rep. 2023 Jul 27;13(1):12150. doi: 10.1038/s41598-023-39444-4.
3
The pathogenic role of intestinal flora metabolites in diabetic nephropathy.
肠道菌群代谢产物在糖尿病肾病中的致病作用。
Front Physiol. 2023 Jul 4;14:1231621. doi: 10.3389/fphys.2023.1231621. eCollection 2023.
4
FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis.胰岛多糖通过调节肠-肾轴改善糖尿病小鼠的肾损伤。
Phytomedicine. 2023 Sep;118:154935. doi: 10.1016/j.phymed.2023.154935. Epub 2023 Jun 20.
5
The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.糖尿病肾病早晚期的肠道微生物组成。
Microbiol Spectr. 2023 Aug 17;11(4):e0038223. doi: 10.1128/spectrum.00382-23. Epub 2023 Jun 21.
6
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study.胃食管反流病与特发性肺纤维化之间的因果关系:一项双向两样本 Mendelian 随机研究。
Eur Respir J. 2023 May 25;61(5). doi: 10.1183/13993003.01585-2022. Print 2023 May.
7
Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study.全身炎症调节因子与慢加急性肝衰竭风险:一项双向孟德尔随机化研究。
Front Cell Dev Biol. 2023 Jan 19;11:1125233. doi: 10.3389/fcell.2023.1125233. eCollection 2023.
8
Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease.靶向药物递送策略:通向糖尿病肾病治疗的桥梁。
Drug Deliv. 2023 Dec;30(1):2160518. doi: 10.1080/10717544.2022.2160518.
9
Gut microbiota: A new target for T2DM prevention and treatment.肠道微生物群:T2DM 预防和治疗的新靶点。
Front Endocrinol (Lausanne). 2022 Aug 11;13:958218. doi: 10.3389/fendo.2022.958218. eCollection 2022.
10
Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives.肠道微生物群与糖尿病肾病:发病机制及治疗前景
World J Diabetes. 2022 Apr 15;13(4):308-318. doi: 10.4239/wjd.v13.i4.308.